Form 4 for ATRA Atara Biotherapeutics, Inc.
Accepted 2024-08-20 00:00:00 ET · period of report 2024-08-16 · accession 0000905148-24-002305 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| M | 2024-08-20 | 2024-08-16 | ATRA | Nguyen AnhCo | EVP, Chief Sci, Tech Off | S - Sale | $6.63 | -1,821 | 34.1K | -5% | -$12.1K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-08-16 | S | D | 297 | $6.63 | 34,174 | D | — | — | (F2) The sale price of the reporting person's shares represents the weighted average price of all shares sold by a broker on August 16, 2024 and August 19, 2024 on behalf of a group of employees of the Issuer to satisfy the payment of withholding tax liability of such employees. |
| 2 | Common | Common Stock | 2024-08-16 | S | D | 1,468 | $6.63 | 34,471 | D | — | — | (F2) The sale price of the reporting person's shares represents the weighted average price of all shares sold by a broker on August 16, 2024 and August 19, 2024 on behalf of a group of employees of the Issuer to satisfy the payment of withholding tax liability of such employees. (F3) This amount reflects the 1:25 reverse stock split effected by the Issuer on June 20, 2024. |
| 3 | Common | Common Stock | 2024-08-16 | S | D | 56 | $6.63 | 34,118 | D | — | — | (F2) The sale price of the reporting person's shares represents the weighted average price of all shares sold by a broker on August 16, 2024 and August 19, 2024 on behalf of a group of employees of the Issuer to satisfy the payment of withholding tax liability of such employees. |